Las reacciones alrgicas serias, aunque raras, pueden manifestarse con angioedema (hinchazn de cara, labios, lengua o garganta), dificultad respiratoria, o anafilaxia, y requieren atencin mdica de emergencia inmediata
In addition to glycemic control and weight loss, certain GLP-1 receptor agonists have FDA-approved indications to lower the risk for major adverse cardiovascular events, address moderate to severe obstructive sleep apnea, and, most recently, reduce the risk for worsening kidney disease, kidney failure, and cardiovascular death
Here are the main ways they support weight loss: You feel less hungry and have fewer food cravings You feel full after eating smaller amounts of food Your blood sugar is better controlled, which can improve overall health For many people, this makes it easier to follow a healthier eating plan and lose weight in a steady, long-term way
At 8mg weekly (standard maintenance): 20mg / 8mg per week = 2.5 weeks per vial Represents the therapeutic sweet spot identified in early trials
2016;94:e170e176
